Propel Bio Management LLC 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-22 2:26 pm Purchase |
2024-02-09 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Management LLC | 8,071,526 10.500% |
3,314,144 (+69.66%) |
Filing |
| 2023-05-02 1:24 pm Purchase |
2023-02-28 | 13G | Applied Therapeutics, Inc. APLT |
Propel Bio Management LLC | 4,757,382 9.900% |
4,757,382 (New Position) |
Filing |